SCHEMBL5264131

SCHEMBL5264131

Nc1sccc1B(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577560 0.72
SCHEMBL868397 0.72 MAPT (0.35)
SCHEMBL28342953 0.70
SCHEMBL18878410 0.67 ALOX5 (0.33)
SCHEMBL18562866 0.67 ENPP2 (0.40)
SCHEMBL3786383 0.67 LIPG (0.37)
SCHEMBL20561503 0.65 MGLL (0.35)
SCHEMBL334122 0.65 KDM4E (0.35)
SCHEMBL3783766 0.65 PRNP (0.39)
SCHEMBL1372166 0.65 AXL (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814883-A1 BICYCLIC INHIBITORS OR RHO KINASE Vertex Pharmaceuticals Incorporated (US) 2007-08-08 EP disclosed
US-20060122185-A1 Bicyclic inhibitors of Rho kinase VERTEX PHARMACEUTICALS INCORPORATED 2006-06-08 US disclosed
WO-2006058120-A1 BICYCLIC INHIBITORS OR RHO KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-01 WO disclosed